Recerca

Genòmica Translacional

Buscador de publicacions

Publicacions

  • Cruz-Martínez O, Caloretti V, Salvador-Hernandez H, Celis-Passini V, Santa-María López V, Morales-La Madrid A, Suñol M, Puerta P, Muchart-Lopez J, Krauel L and Lavarino C.

    Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome

    HEREDITARY CANCER IN CLINICAL PRACTICE . 19(1): 1-1.

    [doi:10.1186/s13053-020-00158-7]

  • Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS.

    Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children

    PEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de cites: 3

    [doi:10.1111/pde.14354]

  • Baroni LV, Rugilo C, Lubieniecki F, Sampor C, Freytes C, Nobre L, Hansford JR, Malalasekera VS, Zapotocky M, Dodgshun A, Martinez OC, Morales-La Madrid A, Lavarino C, Suñol M, Rutkowski S, Schuller U, Bouffet E, Ramaswamy V and Alderete D.

    Treatment response of CNS high-grade neuroepithelial tumors withMN1alteration

    PEDIATRIC BLOOD & CANCER . 67(12): . Nº de cites: 6

    [doi:10.1002/pbc.28627]

  • Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J.

    RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

    Science Advances . 6(43): 3058. Nº de cites: 24

    [doi:10.1126/sciadv.aba3058]

  • Zugbi S, Ganiewich D, Bhattacharyya A, Aschero MR, Ottaviani D, Sampor C, Cafferata EG, Mena M, Sgroi M, Winter U, Lamas G, Suñol M, Daroqui M, Baialardo E, Salas B, Das A, Fandiño A, Francis JH, Lubieniecki F, Lavarino C, Garippa R, Podhjacer OL, Abramson DH, Radvanyi F, Chantada G, Llera AS and Schaiquevich P.

    Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma

    Cancers . 12(9): . Nº de cites: 24

    [doi:10.3390/cancers12092714]

  • Castillo H, Monterrubio C, Pascual-Pastó G, Gomez-Gonzalez S, Garcia-Dominguez DJ, Hontecillas-Prieto L, Resa-Parés C, Burgeño-Sandoval V, Paco-Mercader S, Gene-Olaciregui N, Vilà-Ubach M, Restrepo-Perdomo C, Cuadrado-Vilanova M, Balaguer-Lluna L, Pérez-Jaume S, Castañeda-Heredia A, Santa-María López V, Roldan-Molina M, Suñol M, de Alava E, Mora J, Lavarino C and Carcaboso AM.

    Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

    JOURNAL OF CONTROLLED RELEASE . 324: 440-449. Nº de cites: 6

    [doi:10.1016/j.jconrel.2020.05.032]

  • Fernández-Rodríguez J, Morales-La Madrid A, Gel B, Castañeda-Heredia A, Salvador-Hernandez H, Martínez-Iniesta M, Moutinho C, Morata J, Heyn H, Blanco I, Creus-Bachiller E, Capella G, Farré L, Vidal A, Soldado F, Krauel L, Suñol M, Serra E, Villanueva A and Lázaro C.

    Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor

    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 12: . Nº de cites: 5

    [doi:10.1177/1758835920929579]

  • Pinto EM, Figueiredo BC, Chen W, Galvao HCR, Formiga MN, Fragoso MCBV, Ashton-Prolla P, Ribeiro EMSF, Felix G, Costa TEB, Savage SA, Yeager M, Palmero EI, Volc S, Salvador-Hernandez H, Fuster-Soler JL, Lavarino C, Chantada G, Vaur D, Odone-Filho V, Brugières L, Else T, Stoffel EM, Maxwell KN, Achatz MI, Kowalski L, de Andrade KC, Pappo A, Letouze E, Latronico AC, Mendonca BB, Almeida MQ, Brondani VB, Bittar CM, Soares EWS, Mathias C, Ramos CRN, Machado M, Zhou W, Jones K, Vogt A, Klincha PP, Santiago KM, Komechen H, Paraizo MM, Parise IZS, Hamilton KV, Wang J, Rampersaud E, Clay MR, Murphy AJ, Lalli E, Nichols KE, Ribeiro RC, Rodriguez-Galindo C, Korbonits M, Zhang J, Thomas MG, Connelly JP, Pruett-Miller S, Diekmann Y, Neale G, Wu G and Zambetti GP.

    XAF1 as a modifier of p53 function and cancer susceptibility.

    Science Advances . 6(26): . Nº de cites: 33

    [doi:10.1126/sciadv.aba3231]

  • Renzi S, Michaeli O, Salvador-Hernandez H, Alderete D, Ponce NF, Zapotocky M, Hansford JR, Malalasekera VS, Toledano H, Maguire B, Bouffet E, Ramaswamy V and Baroni LV.

    Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence.

    PEDIATRIC BLOOD & CANCER . 67(5): . Nº de cites: 14

    [doi:10.1002/pbc.28228]

  • González-Acosta M, Marín F, Puliafito B, Bonifaci N, Fernández A, Navarro M, Salvador-Hernandez H, Balaguer F, Iglesias S, Velasco A, Grau Garces E, Moreno V, Gonzalez-Granado LI, Guerra-García P, Ayala R, Florkin B, Kratz C, Ripperger T, Rosenbaum T, Januszkiewicz-Lewandowska D, Azizi AA, Ragab I, Nathrath M, Pander HJ, Lobitz S, Suerink M, Dahan K, Imschweiler T, Demirsoy U, Brunet J, Lázaro C, Rueda D, Wimmer K, Capellá G and Pineda M.

    High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers

    JOURNAL OF MEDICAL GENETICS . 57(4): 269-273. Nº de cites: 17

    [doi:10.1136/jmedgenet-2019-106272]